Can Science Applications International Corporation cover its short-term obligations?

Its current ratio is 1.16 — current assets exceed current liabilities.

Where does Science Applications International Corporation's balance sheet data come from?

Every line is extracted from Science Applications International Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Science Applications International Corporation SAIC Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '27	TTM Q4 '26	TTM Q3 '26	TTM Q2 '26	TTM Q1 '26
Cash and cash equivalents	$117M-38.4%	$190M+258%	$53M-5.4%	$56M+1.8%	$55M-14.1%
Restricted cash	$5M0.0%	$5M0.0%	$5M0.0%	$5M0.0%	$5M0.0%
Accounts receivable, net	$962M+12.8%	$853M-18.4%	$1.05B+9.9%	$951M-5.7%	$1.01B+0.9%
Prepaid expenses and other current assets	$544M+24.8%	$436M+11.2%	$392M+70.4%	$230M—	——
Total current assets	$1.2B+1.7%	$1.18B-6.2%	$1.26B+4.4%	$1.2B+4.9%	$1.15B-0.5%
Property and equipment, net	$111M+0.9%	$110M+1.9%	$108M+3.8%	$104M+2.0%	$102M-1.9%
Accumulated depreciation	$221M+2.8%	$215M+1.4%	$212M+1.0%	$210M+1.9%	$206M+3.0%
Operating lease right-of-use assets	$184M-4.7%	$193M+19.1%	$162M+3.8%	$156M-3.1%	$161M-1.8%
Goodwill	$2.94B0.0%	$2.94B-0.5%	$2.96B+3.8%	$2.85B0.0%	$2.85B0.0%
Intangible assets, net	$729M-4.2%	$761M-2.3%	$779M+8.0%	$721M-3.9%	$750M-3.7%
Deferred tax assets	$125M+20.2%	$104M-16.1%	$124M-6.1%	$132M+500%	$22M-8.3%
Other non-current assets	$171M+2.4%	$167M+6.4%	$157M—	——	——
Total assets	$5.34B-0.3%	$5.35B-1.3%	$5.42B+4.3%	$5.2B-0.2%	$5.21B-0.7%
Accounts payable	——	——	——	——	——
Accrued expenses	$278M-12.0%	$316M+2.6%	$308M-8.3%	$336M+16.7%	$288M+155%
Deferred revenue	——	——	——	——	——
Current portion of long-term debt	$26M+36.8%	$19M+58.3%	$12M-97.3%	$448M+10.6%	$405M+29.4%
Contract liabilities	——	——	——	——	——
Total current liabilities	$1.04B+5.6%	$982M-6.5%	$1.05B-27.4%	$1.45B-1.8%	$1.47B+5.6%
Long-term debt	$2.46B-0.3%	$2.47B-0.3%	$2.48B+34.2%	$1.84B-1.7%	$1.88B-1.6%
Operating lease liabilities, non-current	$189M-4.5%	$198M+24.5%	$159M+3.9%	$153M-4.4%	$160M-7.5%
Other non-current liabilities	$104M+2.0%	$102M-1.0%	$103M-4.6%	$108M-37.9%	$174M+3.0%
Common stock	1B0.0%	1B0.0%	1B0.0%	1B0.0%	1B—
Additional paid-in capital	$0—	$0—	$0—	$0—	$0—
Retained earnings	$1.42B-5.1%	$1.49B-0.8%	$1.5B-0.3%	$1.51B+0.9%	$1.49B-4.5%
Accumulated other comprehensive income (loss)	$7M-12.5%	$8M0.0%	$8M-11.1%	$9M-18.2%	$11M-8.3%
Total stockholders' equity	$1.42B-5.1%	$1.5B-0.8%	$1.51B-0.3%	$1.52B+0.8%	$1.51B-4.6%
Total liabilities and stockholders' equity	$5.34B-0.3%	$5.35B-1.3%	$5.42B+4.3%	$5.2B-0.2%	$5.21B-0.7%
Allowance for Doubtful Accounts	$2M0.0%	$2M-33.3%	$3M+50.0%	$2M—	——
Allowance for Doubtful Accounts Receivable (Current)	$2M0.0%	$2M-33.3%	$3M+50.0%	$2M—	——
Other current assets	$26M+18.2%	$22M0.0%	$22M-26.7%	$30M-67.4%	$92M+360%
Other current assets	——	——	——	——	——
Restricted Cash Equivalents Current	$3M0.0%	$3M0.0%	$3M0.0%	$3M0.0%	$3M0.0%
Deferred Finance Costs, Current	$0—	$0—	$0—	$0—	$0—
Deferred Tax Assets and Other Non-Current Assets	$171M+2.4%	$167M+6.4%	$157M-4.8%	$165M-17.1%	$199M+2.6%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——	——
Finite Lived Intangible Assets - Gross	$1.57B0.0%	$1.57B+0.9%	$1.56B+5.9%	$1.47B0.0%	$1.47B-0.1%
Net Investment in Lease	$184M-4.7%	$193M+19.1%	$162M+3.8%	$156M-3.1%	$161M-1.8%
Intangible assets — net	$729M-4.2%	$761M-2.3%	$779M+8.0%	$721M-3.9%	$750M-3.7%
Operating lease right-of-use assets	$184M-4.7%	$193M+19.1%	$162M+3.8%	$156M-3.1%	$161M-1.8%
Other non-current assets	$171M+2.4%	$167M+6.4%	$157M-4.8%	$165M-17.1%	$199M+2.6%
Operating Lease Right-of-Use Assets in Other Assets	$184M-4.7%	$193M+19.1%	$162M+3.8%	$156M-3.1%	$161M-1.8%
Software and Technology Licenses, Net	$171M+2.4%	$167M+6.4%	$157M-4.8%	$165M-17.1%	$199M+2.6%
Accrued liabilities and other current	$634M+26.8%	$500M-20.3%	$627M—	——	——
Accrued Manufacturing Costs	$278M-12.0%	$316M+2.6%	$308M-8.3%	$336M+16.7%	$288M-15.0%
Accrued Progress Collections and Price Adjustments	——	——	——	——	——
Accrued Vacation Current	——	——	——	——	——
Compensation and benefits	$278M-12.0%	$316M+2.6%	$308M-8.3%	$336M+16.7%	$288M-15.0%
Contract Liabilities, Non-Current	——	——	——	——	——
Debt Maturity - 2024	——	——	——	——	——
Debt Maturity - 2027	——	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$14M0.0%	$14M-12.5%	$16M+100%	$8M0.0%	$8M0.0%
Deferred revenue, net of current portion	——	——	——	——	——
Total debt	$2.68B-1.1%	$2.71B+2.3%	$2.65B+8.2%	$2.45B+0.2%	$2.44B+1.2%
Total Carrying Value of Debt	$2.5B0.0%	$2.5B-0.1%	$2.5B+8.8%	$2.3B+0.5%	$2.29B+2.7%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	43M-2.3%	44M-2.2%	45M-2.2%	46M-2.1%	47M-2.1%
Additional paid-in capital	$0—	$0—	$0—	$0—	$0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$0—	$0—	$0—	$0—	$0—
Accounts Receivable, Allowance for Credit Loss	$2M0.0%	$2M-33.3%	$3M+50.0%	$2M—	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$1B0.0%	$1B0.0%	$1B0.0%	$1B0.0%	$1B0.0%
Common stock, shares issued (in shares)	$43M-2.3%	$44M-2.2%	$45M-2.2%	$46M-2.1%	$47M-2.1%
Common Stock, Shares, Outstanding	$43M-2.3%	$44M-2.2%	$45M-2.2%	$46M-2.1%	$47M-2.1%
Contract with Customer, Asset, Other	——	——	——	——	——
Long-term debt, gross	$2.5B0.0%	$2.5B-0.1%	$2.5B+8.8%	$2.3B+0.5%	$2.29B+2.7%
Principal amount of long-term debt, net of current portion	$2.47B-0.3%	$2.48B-0.4%	$2.49B+34.5%	$1.85B-1.7%	$1.88B-1.6%
Deferred Finance Costs Noncurrent Net	$14M0.0%	$14M-12.5%	$16M+100%	$8M0.0%	$8M0.0%
Deferred income taxes	$125M+20.2%	$104M-16.1%	$124M-6.1%	$132M+500%	$22M-8.3%
Thereafter	——	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$843M+3.9%	$811M+4.1%	$779M+3.9%	$750M+4.0%	$721M+3.9%
2028	——	——	——	——	——
2030	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
Gross Carrying Amount	$1.57B0.0%	$1.57B+0.9%	$1.56B+5.9%	$1.47B0.0%	$1.47B-0.1%
2028	——	——	——	——	——
2029	——	——	——	——	——
2030	——	——	——	——	——
2027	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
Thereafter	——	——	——	——	——
Other accrued liabilities	$99M-32.7%	$147M+42.7%	$103M-2.8%	$106M-6.2%	$113M0.0%
Other Employee Related Liabilities Current	——	——	——	——	——
Prepaid expenses	——	——	——	——	——
Remaining performance obligation	——	——	——	——	——
Remaining sold receivables(3)	——	——	——	——	——
TransferOfFinancialAssetsAccountedForAsSalesAmountOutstanding	$164M0.0%	$164M-34.4%	$250M-5.7%	$265M-11.7%	$300M+82.9%
TransfersOfFinancialAssetsAccountedForAsSalesCashCollectedNotRemittedToPurchaser	——	——	——	——	——
Maximum commitment	——	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Science Applications International Corporation cover its short-term obligations?: Its current ratio is 1.16 — current assets exceed current liabilities.
Where does Science Applications International Corporation's balance sheet data come from?: Every line is extracted from Science Applications International Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.